4//SEC Filing
McCulloch Kevin 4
Accession 0002031695-25-000004
CIK 0001867096other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:33 PM ET
Size
7.0 KB
Accession
0002031695-25-000004
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Other
Common Stock
2025-09-11−2,000→ 0 total(indirect: By Trust)
Holdings
- 25,000(indirect: By Spouse)
Common Stock
- 1,701,159
Common Stock
Footnotes (2)
- [F1]The reporting person is trustee of the Charles R. McCulloch Trust, of which he is a beneficiary. On September 11, 2025, the reporting person caused the trust to distribute 2,000 shares of the Issuer's common stock to a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. No sale of shares occurred in the transfer.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0002031695
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 5:33 PM ET
- Size
- 7.0 KB